In addition to multiple molecular mechanisms underlying liver metastasis in breast cancer patients, a positive correlation between the occurrence of liver metastasis and multiple clinicopathological features, such as young age, invasive ductal carcinoma, higher pathological grade, and subtype of HER2+, was found in our study. The gene discussed is ERBB2; the disease is breast carcinoma.